# ABBOTT LABORATORIES (ABT) FY2026 YTD Q2 P&L / Income Statement

- Company: ABBOTT LABORATORIES (ABT)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-28, accession number 0001628280-26-050134
- Page: https://plicit.ai/financials/abt/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/abt-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Business Segment

Income statement for 2026-01-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 23,757,000,000 US dollars
- **Cost of products sold, excluding amortization of intangible assets**: 10,215,000,000 US dollars
- **Gross profit (calculated)**: 13,542,000,000 US dollars
- **Operating expenses (calculated)**: 10,504,000,000 US dollars
- **Operating earnings**: 3,038,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 65,000,000 US dollars
- **Earnings before taxes**: 2,973,000,000 US dollars
- **Taxes on earnings**: 968,000,000 US dollars
- **Net Earnings**: 2,005,000,000 US dollars
- **Established Pharmaceutical Products**: 2,925,000,000 US dollars
- **Nutritional Products**: 4,161,000,000 US dollars
- **Diagnostic Products**: 5,272,000,000 US dollars
- **Medical Devices**: 11,392,000,000 US dollars
- **Amortization of intangible assets**: 1,080,000,000 US dollars
- **Research and development**: 1,659,000,000 US dollars
- **Selling, general, and administrative**: 7,765,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 23,750,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Other**: 7,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Established Pharmaceutical Products costs (calculated)**: 2,178,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Nutritional Products costs (calculated)**: 3,482,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Diagnostic Products costs (calculated)**: 4,438,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Medical Devices costs (calculated)**: 7,530,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Reconciling items (calculated)**: 3,091,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/abt/fy2026-ytd-q2-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/abt-fy2026-ytd-q2-revenue-by-geography-sankey.png

Income statement for 2026-01-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 23,757,000,000 US dollars
- **Cost of products sold, excluding amortization of intangible assets**: 10,215,000,000 US dollars
- **Gross profit (calculated)**: 13,542,000,000 US dollars
- **Operating expenses (calculated)**: 10,504,000,000 US dollars
- **Operating earnings**: 3,038,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 65,000,000 US dollars
- **Earnings before taxes**: 2,973,000,000 US dollars
- **Taxes on earnings**: 968,000,000 US dollars
- **Net Earnings**: 2,005,000,000 US dollars
- **UNITED STATES**: 9,490,000,000 US dollars
- **International**: 14,267,000,000 US dollars
- **Amortization of intangible assets**: 1,080,000,000 US dollars
- **Research and development**: 1,659,000,000 US dollars
- **Selling, general, and administrative**: 7,765,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.